304 related articles for article (PubMed ID: 16253594)
1. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
Muntner P; Gu D; Reynolds RF; Wu X; Chen J; Whelton PK; He J
Am J Cardiol; 2005 Nov; 96(9):1260-5. PubMed ID: 16253594
[TBL] [Abstract][Full Text] [Related]
2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
4. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
Hyre AD; Muntner P; Menke A; Raggi P; He J
Ann Epidemiol; 2007 Jul; 17(7):548-55. PubMed ID: 17395483
[TBL] [Abstract][Full Text] [Related]
5. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
[TBL] [Abstract][Full Text] [Related]
6. Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.
Clearfield M; Downs JR; Lee M; Langendorfer A; McConathy W; Gotto AM
Am J Cardiol; 2005 Dec; 96(12):1674-80. PubMed ID: 16360356
[TBL] [Abstract][Full Text] [Related]
7. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
Persell SD; Lloyd-Jones DM; Baker DW
J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
[TBL] [Abstract][Full Text] [Related]
8. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
[TBL] [Abstract][Full Text] [Related]
9. National Cholesterol Education Program Adult Treatment Panel III guidelines and obesity: implications for Canada.
Ardern CI; Katzmarzyk PT
Can J Cardiol; 2003 Sep; 19(10):1171-7. PubMed ID: 14532943
[TBL] [Abstract][Full Text] [Related]
10. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):109-14. PubMed ID: 21293326
[TBL] [Abstract][Full Text] [Related]
11. Practical application of Adult Treatment Panel III guidelines: three illustrative case histories.
Carr LL
J Am Osteopath Assoc; 2002 May; 102(5 Suppl 1):S12-4. PubMed ID: 12046680
[TBL] [Abstract][Full Text] [Related]
12. Measuring and treating serum lipids in patients in a chest pain observation unit.
Gillespie MJ; Davis CJ; Lambert ND; Costello FM; Smith SC; Cohen MG; Menon V
Am J Cardiol; 2007 Jun; 99(12):1718-20. PubMed ID: 17560881
[TBL] [Abstract][Full Text] [Related]
13. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
Gotto AM; Kuller LH
Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
[No Abstract] [Full Text] [Related]
14. Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease. Application of the Second Adult Treatment Panel guidelines.
Allen JK; Young DR; Blumenthal RS; Moy TF; Yanek LR; Wilder L; Becker LC; Becker DM
Arch Intern Med; 1996 Aug 12-26; 156(15):1654-60. PubMed ID: 8694663
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
16. Adult Treatment Panel III: do we really need another set of cholesterol guidelines?
Clearfield MB
J Am Osteopath Assoc; 2002 May; 102(5 Suppl 1):S6-11. PubMed ID: 12046681
[TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
Rosenson R; Lloyd-Jones D;
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
[TBL] [Abstract][Full Text] [Related]
18. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
19. [New results in the management of hypercholesterolemia].
Sármán B
Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
[TBL] [Abstract][Full Text] [Related]
20. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
